Journey Medical Corp
DERM
$7.36-0.01%
Delayed · as of Sep 16, 2026, 1:00 PM ET
Mkt cap
$163.07M
EV/Sales
2.66
P/E ratio
N/A
FY2025 Revenue
$61.86M
EPS (TTM)
$-0.22
Gross Margin (FY2025)
66.17%
Profit Margin (FY2025)
-18.48%
Beta
0.88
Div yield
N/A
Sector
Healthcare
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DERM revenue for 2025-12-31 was $61.9M. Net income was -$11.4M. Revenue was up 10.2% from 2024-12-31 to 2025-12-31. DERM currently screens at market cap $163.1M.
Use this DERM research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full DERM income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Journey Medical Corp (DERM) revenue for Dec 31, 2025 was $61.9M. Net income was -$11.4M. Statements: https://lician.com/financials/derm
Journey Medical Corp (DERM) market capitalization is $163.1M on the latest cached snapshot.
Journey Medical Corp (DERM) cached previous close $7.36; day range $7.36 – $7.62; volume 48,571. Session quote: https://lician.com/quote/derm
Journey Medical Corp (DERM) latest cached earnings event is "DERM earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached DERM filing is 8-K · Jun 26, 2026. Filings: https://lician.com/sec/derm